Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party.

Saved in:
Bibliographic Details
Title: Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party.
Authors: Berghmans T; Department of Intensive Care and Oncological Emergencies and Thoracic Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles , Brussels , Belgium., Ameye L; Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB) , Brussels , Belgium., Lafitte JJ; Department of Pulmonary and Thoracic Oncology, Centre Hospitalier Régional Universitaire de Lille , Lille , France., Colinet B; Department of Pneumology, Grand Hôpital de Charleroi, site Saint-Joseph , Gilly , Belgium., Cortot A; Department of Pulmonary and Thoracic Oncology, Centre Hospitalier Régional Universitaire de Lille , Lille , France., CsToth I; Department of Intensive Care and Oncological Emergencies and Thoracic Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles , Brussels , Belgium., Holbrechts S; Department of Oncology, Hôpital Ambroise Paré , Mons , Belgium., Lecomte J; Department of Pneumology, CH Charleroi , Charleroi , Belgium., Mascaux C; Department of Intensive Care and Oncological Emergencies and Thoracic Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles , Brussels , Belgium ; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre , Toronto, ON , Canada., Meert AP; Department of Intensive Care and Oncological Emergencies and Thoracic Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles , Brussels , Belgium., Paesmans M; Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB) , Brussels , Belgium., Richez M; Department of Pneumology, CHR St Joseph , Warquignies , Belgium., Scherpereel A; Department of Pulmonary and Thoracic Oncology, Centre Hospitalier Régional Universitaire de Lille , Lille , France., Tulippe C; Department of Pneumology, CH Mouscron , Mouscron , Belgium., Willems L; Laboratory of Molecular and Cellular Biology, Université de Liège , Gembloux , Belgium., Dernies T; Department of Intensive Care and Oncological Emergencies and Thoracic Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles , Brussels , Belgium., Leclercq N; Department of Intensive Care and Oncological Emergencies and Thoracic Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles , Brussels , Belgium., Sculier JP; Department of Intensive Care and Oncological Emergencies and Thoracic Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles , Brussels , Belgium.
Corporate Authors: European Lung Cancer Working Party
Source: Frontiers in oncology [Front Oncol] 2015 Jan 28; Vol. 4, pp. 386. Date of Electronic Publication: 2015 Jan 28 (Print Publication: 2014).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2014.00386